Vimarsana
Biggest News Aggregation in the World

Invox Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Invox Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Invox Pharma Today - Breaking & Trending Today

Bispecific Antibody Clinical Trial Pipeline Appears Robust With 250+ Key Pharma Companies Actively Working in the Therapeutics Segment - Vimarsana News

Bispecific Antibody Clinical Trial Pipeline Appears Robust With 250+ Key Pharma Companies Actively Working in the Therapeutics Segment

/PRNewswire/ -- DelveInsight's 'Bispecific Antibody Competitive Landscape – 2023' report provides comprehensive global coverage of available, marketed, and...

Dow Surges 250 Points; Jobless Claims Rise To 225,000 - Vimarsana News

Dow Surges 250 Points; Jobless Claims Rise To 225,000

U.S. stocks traded higher this morning, with the Dow Jones gaining around 250 points on Thursday. Following the market opening Thursday, The Dow ...

F-STAR THERAPEUTICS ALERT: Bragar Eagel & Squire, P.C. - Vimarsana News

F-STAR THERAPEUTICS ALERT: Bragar Eagel & Squire, P.C.

NEW YORK, June 24, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an...

Biopharma firm Radius Health is going private in an $890M M&A deal - Vimarsana News

Biopharma firm Radius Health is going private in an $890M M&A deal

Two private equity firms have reached an $890 million deal to buy Radius Health, a company whose main asset is the commercialized osteoporosis drug Tymlos. In other M&A news, cancer biotech F-star Therapeutics is being acquired in a $161 million deal.